GPCR Diffusive Dynamics Evaluation via Single-Molecule Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for evaluating the activity of G protein-coupled receptors (GPCRs) are inadequate, particularly for orphan receptors, as the downstream signaling pathways are often unknown, making it difficult to assess the medicinal effects of substances targeting these receptors.

Innovation Solution

A method involving single-molecule imaging to quantify the diffusive dynamics of GPCR molecules on the cell membrane, where the target substance's effect is determined by measuring the mean square displacement or average diffusion coefficient, allowing for the identification of agonists and inverse agonists.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional downstream cell response methods are used to evaluate GPCR activity, then the evaluation can be performed using established assays, but the method fails for orphan GPCRs because their downstream signaling pathways are unknown

Engineering Contradiction:
Improveapplicability to orphan GPCRsVSAvoidevaluation accuracy
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The invention extracts the GPCR molecules from the complex downstream signaling pathways and directly images their diffusive dynamics on the cell membrane. By focusing on the receptor molecules themselves rather than their downstream effects, the method bypasses the need for known signaling pathways, enabling evaluation of orphan GPCRs while maintaining measurement precision through direct molecular observation

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces fluorescent labels as intermediaries to tag GPCR molecules, enabling their direct visualization and tracking. This intermediary approach allows the measurement of receptor activity through diffusive dynamics without requiring knowledge of downstream pathways, thus resolving the contradiction between versatility for orphan GPCRs and measurement precision

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If single-molecule imaging is used to directly observe GPCR diffusive dynamics, then the method can evaluate any GPCR including orphans, but the technical complexity of the measurement system increases

Engineering Contradiction:
Improveapplicability to all GPCR typesVSAvoidimaging system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention employs fluorescent labels that inherently provide the necessary contrast and tracking capability for single-molecule imaging. The labeled GPCR molecules serve their own detection function through their natural diffusive motion on the cell membrane, reducing the need for complex external measurement systems while maintaining broad applicability to all GPCR types

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention changes the observation parameter from downstream cellular responses to the diffusive dynamics parameters (mean square displacement, diffusion coefficient) of the GPCR molecules themselves. This parameter change enables universal application to all GPCR types while using relatively simple fluorescence microscopy equipment rather than complex signaling pathway assays

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables efficient evaluation of medicinal substances targeting GPCRs, including orphan receptors, by correlating diffusive dynamics with receptor activity, facilitating the identification of prophylactic or therapeutic agents.

Implementation Method 1

the GPCR includes a fluorescent label on a C-terminus

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS11002728B2Method for evaluating activity of G protein-coupled receptor (GPCR)
Publication Date: 2021.05.11 RIKEN CO LTD
  • US11002728B2 patent drawing
  • US11002728B2 patent drawing
  • US11002728B2 patent drawing

AI summary

It is an object to provide a method for evaluating a medicinal substance targeting a G protein-coupled receptor (GPCR). Specifically, the present invention relates to a method for evaluating the activity of a GPCR comprising a step of bringing a target substance into contact with a cell expressing a GPCR on the cell membrane; and a step of determining the diffusive dynamics of the GPCR on the cell membrane.